Bellvitge Biomedical Research Institute (IDIBELL)
If you are the contact person for this centre and you wish to make any changes, please contact us.
ICREA Research Professor and Coordinator of the Regenerative Medicine Programme at the Bellvitge Biomedical Research Institute (IDIBELL), member of CIBER-BBN, Director of the Clinical Translation Programme in Regenerative Medicine in Catalonia, and Professor of Physiology at the University of Barcelona.
Lecturer of the Department of Social Psychology and Quantitative Psychology at the University of Barcelona, researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and CIBERSAM
Head of the Hereditary Cancer Research Group at the Catalan Institute of Oncology-IDIBELL
Coordinator of the Neuro-oncology Unit of the Bellvitge Biomedical Research Institute (IDIBELL) and researcher of the Neuroplasticity and Regeneration Group of the Autonomous University of Barcelona
Principal investigator, Digital Health Programme ICOnnecta't, and member of the Group of Psycho-oncology and Digital Health at IDIBELL
Head of the Cancer Virotherapy Group at the Bellvitge Biomedical Research Institute (IDIBELL).
Head of Medical Oncology at the Catalan Institute of Oncology (ICO), head of the Colorectal Cancer Research Group, Oncobell programme (IDIBELL) and associate professor of Medicine at the University of Barcelona
Principal Investigator of the Nutrition and Cancer Unit of the Catalan Institute of Oncology (ICO) and the Bellvitge Biomedical Research Institute (IDIBELL)
Emeritus researcher at the Catalan Institute of Oncology (ICO), senior researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and lecturer in the Faculty of Health Sciences at the Universitat Oberta de Catalunya (UOC)
In the United States, the human papillomavirus vaccine began to be recommended in 2006 for girls aged 9-26 years. A study published in the journal JAMA Health Forum concludes that the campaign significantly reduced the risk of HPV infection in vaccinated women. In addition, herd immunity reduced the likelihood of infection in unvaccinated women.